Clinical Care Options: Adjuvant HER2-Positive Cancer: Integrating Prognostic Tools and Clinical Advances to Optimize Treatment
Peer Review for material titled "Clinical Care Options: Adjuvant HER2-Positive Cancer: Integrating Prognostic Tools and Clinical Advances to Optimize Treatment"
User Rating for material titled "Clinical Care Options: Adjuvant HER2-Positive Cancer: Integrating Prognostic Tools and Clinical Advances to Optimize Treatment"
Member Comments for material titled "Clinical Care Options: Adjuvant HER2-Positive Cancer: Integrating Prognostic Tools and Clinical Advances to Optimize Treatment"
Personal Collections for material titled "Clinical Care Options: Adjuvant HER2-Positive Cancer: Integrating Prognostic Tools and Clinical Advances to Optimize Treatment"
Learning Exercises for material titled "Clinical Care Options: Adjuvant HER2-Positive Cancer: Integrating Prognostic Tools and Clinical Advances to Optimize Treatment"
Accessibility Info for material titled "Clinical Care Options: Adjuvant HER2-Positive Cancer: Integrating Prognostic Tools and Clinical Advances to Optimize Treatment"
Search all MERLOT
Click here to go to your profile
Select to go to your workspace
Click here to go to your Dashboard Report
Click here to go to your Content Builder
Click here to log out
Search Terms
Enter username
Enter password
Please give at least one keyword of at least three characters for the search to work with. The more keywords you give, the better the search will work for you.
select OK to launch help window
cancel help

MERLOT II




        

Search > Material Results >

Clinical Care Options: Adjuvant HER2-Positive Cancer: Integrating Prognostic Tools and Clinical Advances to Optimize Treatment

        

Clinical Care Options: Adjuvant HER2-Positive Cancer: Integrating Prognostic Tools and Clinical Advances to Optimize Treatment

Logo for Clinical Care Options: Adjuvant HER2-Positive Cancer: Integrating Prognostic Tools and Clinical Advances to Optimize Treatment
This management series contains modules, interactive case challenges, and slidesets by experts concerning HER2-positive breast cancer. Topics include Current Clinical Data on Adjuvant Therapy for HER2-Positive Breast Cancer, Estimating Benefit and Prognosis With Adjuvant Therapy for HER2-Positive Breast Cancer, Treatment of a 32-Year-Old Patient With HER2-Positive Breast Cancer, Treatment of Breast Cancer in a 64-Year-Old Black Female With Multiple Positive Lymph Nodes, and Assessing Breast... More
Material Type: Collection
Technical Format: HTML/Text
Date Added to MERLOT: January 18, 2011
Date Modified in MERLOT: January 18, 2011
Author:
Send email to info@clinicaloptions.com
Keywords: HER2-based adjuvant regimens, interactive case challenges, HER2-positive breast cancer, modules, expert discussions, treatment

Quality

  • Reviewed by members of Editorial board for inclusion in MERLOT.
    Editor Review
    Very good quality; in queue to be peer reviewed
    avg: 5 rating
  • User Rating (not rated)
  • Comments (none)
  • Learning Exercises (none)
  • Personal Collections (none)
  • Accessibility Info (none)

About

Primary Audience: Graduate School, Professional
Mobile Compatibility: Not specified at this time
Language: Portuguese, French, English, Italian, German, Chinese, Spanish
Material Version: 0
Cost Involved: unsure
Source Code Available: no
Accessiblity Information Available: no
Creative Commons: no

Connections





QR Code for this Page

Browse in Categories

Discussion

Discussion for Clinical Care Options: Adjuvant HER2-Positive Cancer: Integrating Prognostic Tools and Clinical Advances to Optimize Treatment

Log in to participate in the discussions or Register if you are not already a MERLOT member.

Return to Top of Page